US Patent 11859000 Anti-CCR8 antibodies and uses thereof
Patent 11859000 was granted and assigned to Vaccinex, Inc on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 4 Jan, 2024
Golden AI
Edits made to:
Infobox (+33 properties)
Article (+402 characters)
US Patent 11859000 Anti-CCR8 antibodies and uses thereof
Article
Patent abstract
The present disclosure is directed to antibodies or antigen-binding portions thereof that specifically bind human CCR8, polynucleotides and vectors encoding the same, and pharmaceutical compositions comprising the same. Some aspects of the disclosure are directed to methods of treating a disease or condition comprising administering the anti-CCR8 antibody to a subject in need thereof.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Andrew Lake0
Austin Dulak0
Caroline Harvey0
Christopher Converse Wells0
Ernest Smith0
Leslie Balch0
Maria Scrivens0
Pamela M. Holland0
Renee Kirk0
Sonia G. Das0
Date of Patent
January 2, 2024
0Patent Application Number
171428620
Date Filed
January 6, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11859000 Anti-CCR8 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
